
                <!DOCTYPE html>
                <html lang="en">
                <head>
                    <meta charset="UTF-8">
                    <meta name="viewport" content="width=device-width, initial-scale=1.0">
                    <title>Past Awards – EURETINA</title>
                </head>
                <body>
                    <h1>Past Awards – EURETINA</h1>
                    <h2>Headings:</h2>
                    <h1>Past Euretina RMCR Awards</h1><h1>You might also like</h1><h1>EURETINA Educational Webinar: Age-Related Macular Degeneration & Central Serous Chorioretinopathy (26 June 2024)</h1><h1>Episode 46: How do you investigate your uveitis patient in 2024?</h1><h1>EURETINA Educational Webinar: Diabetes and Vascular Eye Disease (09 July 2024)</h1>
                    <h2>Paragraphs:</h2>
                    <p>Since the awards programme was established in 2018, we have received a high number of high-quality submissions, and progressed with new awards every year. We are proud to share the winners of past research awards below.</p><p>Any queries should be directed to[email protected]</p><p>Maximillian Pfau, Switzerland: €282,129Enhanced vision and imaging test for enabling treatment trials in early and intermediate AMD</p><p>Javier Zarranz-Ventura, Spain: €227,503Prediction of treatment needs using a hybrid Artificial Intelligence-based Management Assistant (ALMA) tool in Neovascular Age-related Macular Degeneration</p><p></p><p>Pearse A. Keane, United Kingdom: €120,994Predicting progressive macular atrophy in patients undergoing anti-VEGF therapy for neovascular age-related macular degeneration using multi-modal imaging, genetics, and artificial intelligence</p><p>João Pedro Marques, Portugal: €299,879“EYS on” gene editing for Retinitis Pigmentosa 25</p><p>Enrico Borrelli, Italy: €263,806The role of mitochondria in geographic atrophy progression in age-related macular degeneration</p><p></p><p>Suzanne Yzer, The Netherlands: €186,091Risk of posterior staphyloma in highly myopic Europeans: from epidemiology to anatomy and back</p><p>Claudia Farinha, Portugal:€294,704Diet, lifestyle, systemic medication and genetics: can the risk for AMD be modulated? (AMD_LifeGene)</p><p>Robert P. Finger, Germany:€293,350Microbiome, metabolome and complement activation in age-related macular degeneration at the University Hospital Bonn</p><p>Dominik Fischer, UK:€287,359REGENT (RETiNal GENE ThERapy immuNE REsponNsE) atOxford University Hospitals NHS Foundation Trust</p><p></p><p>Rufino Martins da Silva, Portugal:€223,981,59Metabolomics: An Integrative Tool for Investigating the Pathogenesis of Age-related Macular Degeneration at AIBILI – Association for Innovation and Biomedical Research on Light and Image</p><p>Gian Marco Tosi, Italy:€190,752.50The C-type lectin receptor CD93 as a new target in retinal vascular diseases at the University of Siena</p><p></p><p>Camiel Boon, The Netherlands: €201,233Juvenile X-linked retinoschisis: assessing the clinical and genetic spectrum in preparation for therapy</p><p>Roy Schwartz, UK: €262,112Deep learning, large datasets, genome-wide analysis and histological correlates to determine the role of reticular pseudodrusen in the progression of age-related macular degeneration</p><p>Secretariat AddressEuropean Society of Retina SpecialistsReinacherstrasse 1314053 BaselSwitzerland</p><p>T +41 61 686 77 91F +41 61 686 77 88</p><p>Email:[email protected]</p><p>EURETINA 2024 Barcelona</p><p>Euretina Innovation Spotlight (EIS) 2024</p><p>Special Focus Meeting 2024</p><p>Ophthalmologica</p><p>Forum</p><p>Opportunities</p><p>Memberships</p><p>About</p><p>Code of Conduct</p><p>Privacy Policy</p><p>Contact Us</p><p>Newsletter Sign up</p><p>Follow us</p><p>© EURETINA 2024 All rights reserved</p>
                </body>
                </html>
            